HHS to stop funding ‘dangerous’ life sciences research

Paige Twenter / beckershospitalreview - The federal government will stop funding what it determines to be “dangerous” gain-of-function research conducted in the U.S. and abroad after implementing a new policy. The “Policy for Stopping High-Risk Life Sciences Research” lands during broader uphea…

AI Summary: The federal government announced a new policy curbing federal funding for defined categories of high‑risk life‑sciences research, citing biosafety and biosecurity concerns. The move pauses support for experiments judged to pose elevated pandemic or containment risks, sparking debate about how to balance oversight, scientific progress and public safety without stifling useful innovation.

#publichealth #governmentpolicy #biotech #zoonoticdisease #infectiousdisease #researchfunding

28 hrs / oncodaily

28 hrs / oncodaily


Back to Top / Sat, August 1, 2026, 1:23 am / permalink 28002 / 3 stories in 17 hrs /




Related Stories


Fauci faces Senate scrutiny over COVID origins, invoking legal protections / 14 hrs

Republic of the Congo declares mpox outbreak over amid viral diversity findings / 3 months

Congo Ebola outbreak tops 100 deaths as response lags / 7 wks

Congo Ebola outbreak intensifies as response faces attacks and quarantines / 11 days

Healthcare workers strike amid worsening Ebola outbreak in Congo / 25 days

WHO declares cruise ship-linked hantavirus outbreak over / 4 wks

Cruise ship Andes‑virus case prompts testing and contact tracing / 2 months

StackHealth RSS


You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Zoonotic Disease, Eli Lilly, Wildlife, Medical Devices and look for the RSS link.





NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.